No Data
No Data
Calculating The Intrinsic Value Of Tellgen Corporation (SZSE:300642)
Tellgen Corporation (300642.SZ): Subsidiary's application for medical instruments registration has been accepted.
Tellgen Corporation (300642.SZ) announced that its wholly-owned subsidiary jiangxi tellgen Technology Co., Ltd. ("jiangxi...
There is a risk of diffusion! WHO has launched a global strategic preparedness, and monkeypox concept stocks have surged in response.
New variant appears.
Perspective Life: 2024 Semi-Annual Report
Perspective Life: 2024 Semi-Annual Report Summary
Tellgen Corporation (300642.SZ): Net income for the first half of the year was 6.634 million yuan, a year-on-year decrease of 80.97%.
Tellgen Corporation (300642.SZ) announced its 2024 interim report on August 26. During the reporting period, the total operating income was 0.216 billion yuan, a decrease of 21.86% year-on-year; net income attributable to shareholders of the listed company was 6.634 million yuan, a decrease of 80.97% year-on-year; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 3.1117 million yuan, a decrease of 87.98% year-on-year; and the basic earnings per share was 0.0409 yuan.
No Data
No Data